JP2018502150A5 - - Google Patents

Download PDF

Info

Publication number
JP2018502150A5
JP2018502150A5 JP2017549559A JP2017549559A JP2018502150A5 JP 2018502150 A5 JP2018502150 A5 JP 2018502150A5 JP 2017549559 A JP2017549559 A JP 2017549559A JP 2017549559 A JP2017549559 A JP 2017549559A JP 2018502150 A5 JP2018502150 A5 JP 2018502150A5
Authority
JP
Japan
Prior art keywords
contrast agent
imaging
applications
metal
support application
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017549559A
Other languages
English (en)
Japanese (ja)
Other versions
JP6796594B2 (ja
JP2018502150A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2015/051304 external-priority patent/WO2016090491A1/en
Publication of JP2018502150A publication Critical patent/JP2018502150A/ja
Publication of JP2018502150A5 publication Critical patent/JP2018502150A5/ja
Application granted granted Critical
Publication of JP6796594B2 publication Critical patent/JP6796594B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017549559A 2014-12-11 2015-12-10 造影剤およびその用途 Active JP6796594B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201462090519P 2014-12-11 2014-12-11
US62/090,519 2014-12-11
US201562189414P 2015-07-07 2015-07-07
US62/189,414 2015-07-07
PCT/CA2015/051304 WO2016090491A1 (en) 2014-12-11 2015-12-10 Targeted contrast agents comprising a hydrazide functional group

Publications (3)

Publication Number Publication Date
JP2018502150A JP2018502150A (ja) 2018-01-25
JP2018502150A5 true JP2018502150A5 (enExample) 2019-01-24
JP6796594B2 JP6796594B2 (ja) 2020-12-09

Family

ID=56106370

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017549559A Active JP6796594B2 (ja) 2014-12-11 2015-12-10 造影剤およびその用途

Country Status (6)

Country Link
US (1) US10286090B2 (enExample)
EP (1) EP3229848B1 (enExample)
JP (1) JP6796594B2 (enExample)
CN (1) CN106999610A (enExample)
CA (1) CA2968261C (enExample)
WO (1) WO2016090491A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101864992B1 (ko) * 2017-03-09 2018-07-04 국립암센터 Mri 노이즈 제거용 조성물 및 이를 이용한 패드
CN107353258B (zh) * 2017-06-19 2019-09-24 南京科技职业学院 两种二核含钆磁共振成像对比剂及其制备与应用
CN110511176A (zh) * 2019-09-12 2019-11-29 陕西科技大学 双(2-邻苯二甲酰亚胺)胺及其制备方法
CN111606838B (zh) * 2020-06-19 2023-06-30 宁夏大学 一种双吲哚基甲烷类化合物的制备方法
CN111825703B (zh) * 2020-08-04 2023-06-23 江西司太立制药有限公司 一种钆贝葡胺注射液杂质的制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3621018A (en) 1968-06-28 1971-11-16 Hooker Chemical Corp 2,6-diketo-n-carboxymethylmorpholine
US5679810A (en) 1990-01-19 1997-10-21 Salutar, Inc. Linear oligomeric polychelant compounds
US6875864B2 (en) 1991-08-01 2005-04-05 Bracco International B.V. Aminocarboxylate ligands having substituted aromatic amide moieties
DE19744003B4 (de) * 1997-09-26 2004-07-08 Schering Ag Kontrastmittel für das Infarkt- und Nekroseimaging
US6093382A (en) 1998-05-16 2000-07-25 Bracco Research Usa Inc. Metal complexes derivatized with folate for use in diagnostic and therapeutic applications
EP0998946A1 (en) 1998-08-14 2000-05-10 K.U. Leuven Research & Development Non-porphyrin compound for use as a diagnosticum and/or pharmaceutical
US6146615A (en) 1999-01-11 2000-11-14 The University Of Toledo Contrast agents for image enhancement in magnetic resonance imaging
US6641797B2 (en) 2000-08-11 2003-11-04 Schering Aktiengesellschaft Perfluoroalkyl-containing complexes with sugar radicals, process for their production and their use
GB2368843A (en) 2000-11-08 2002-05-15 Leuven K U Res & Dev Non-porphyrin multipurpose contrast agents
AU2002218075A1 (en) 2000-11-08 2002-05-21 K.U. Leuven Research And Development Substituted bis-indole derivatives useful as contrast agents, pharmaceutical compositions containing them and intermediates for producing them
DE10105014C2 (de) 2001-01-26 2003-03-27 Schering Ag Neues Verfahren zur Herstellung von Monoamiden der DTPA
ATE411819T1 (de) * 2003-02-17 2008-11-15 Upperton Ltd Konjugate für medizinische abbildungen umfassend träger, targeting-anteile und kontrastmittel
GB0317467D0 (en) 2003-07-25 2003-08-27 Leuven K U Res & Dev Tissue infraction and necrosis specific compounds
WO2008088648A2 (en) * 2007-01-11 2008-07-24 Immunomedics, Inc. Methods and compositions for improved f-18 labeling of proteins, peptides and other molecules
EP2651411B1 (en) 2010-12-13 2020-09-16 Immunomedics, Inc. Methods and compositions for improved f-18 labeling of proteins, peptides and other molecules
CN103547290A (zh) * 2011-04-20 2014-01-29 Rf医疗公司 靶向造影剂及其用途

Similar Documents

Publication Publication Date Title
JP2018502150A5 (enExample)
Cole et al. Targeted delivery to bone and mineral deposits using bisphosphonate ligands
EP4541378A3 (en) Compounds for positron emission tomography
JP2018058847A5 (enExample)
JP2013521287A5 (enExample)
JP2018502120A5 (enExample)
JP2012255026A5 (enExample)
WO2016046793A3 (en) Radiopharmaceutical conjugate of a metabolite and an epr agent, for targeting tumour cells
WO2015183346A3 (en) Imaging and treatment of pathophysiologic conditions by cerenkov radiation
JP2020097577A5 (enExample)
MY163136A (en) Peptide radiotracer compositions
JP2016527202A5 (enExample)
WO2010039609A3 (en) Conjugates of hexose and metal coordinating compounds for imaging purposes
WO2009052970A3 (en) Compounds for use in imaging, diagnosing, and/or treatment of diseases of the central nervous system or of tumors
ATE411819T1 (de) Konjugate für medizinische abbildungen umfassend träger, targeting-anteile und kontrastmittel
NZ710436A (en) Biospecific agents for bone
WO2020103961A3 (zh) 一种脑部肿瘤靶向肽及其应用
JP2016526021A5 (enExample)
JP2011519367A5 (enExample)
JP2018524306A5 (enExample)
JP2018523657A5 (enExample)
JP2018502829A5 (enExample)
JP2013509378A5 (enExample)
Karpuz et al. Clinical applications of nanosized drug-delivery systems in lung cancer imaging and therapy
JP6921312B2 (ja) 薬学的組成物、その製造方法および使用方法